1. The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery
- Author
-
M.M.P.J. Reijnen, Mare M.A. Lensvelt, Clark J. Zeebregts, J. G. Roukema, Otmar R. M. Wikkeling, J. A. Van Oostayen, Man, Biomaterials and Microbes (MBM), and Vascular Ageing Programme (VAP)
- Subjects
Male ,SAPHENOUS-VEIN ,Time Factors ,Technical success ,Occlusive disease ,Femoropopliteal bypass ,Constriction, Pathologic ,DISEASE ,Medicine ,Popliteal Artery ,Prospective Studies ,Treatment Failure ,Polytetrafluoroethylene ,Netherlands ,Superficial femoral artery ,Endovascular Procedures ,Graft Occlusion, Vascular ,endograft ,General Medicine ,Middle Aged ,Limb Salvage ,Femoral Artery ,Dissection ,medicine.anatomical_structure ,Bypass surgery ,Female ,Stents ,Cardiology and Cardiovascular Medicine ,Vascular Surgical Procedures ,Artery ,Reoperation ,medicine.medical_specialty ,complications ,Prosthesis Design ,Blood Vessel Prosthesis Implantation ,Peripheral Arterial Disease ,Humans ,Ankle Brachial Index ,Vascular Patency ,ARTERY ,Aged ,femoropopliteal bypass ,Groin ,business.industry ,GRAFT ,Surgery ,Blood Vessel Prosthesis ,Radiography ,Evaluation of complex medical interventions [NCEBP 2] ,business - Abstract
Item does not contain fulltext Redo femoropopliteal bypass surgery is associated with increased morbidity and related to a poorer outcome than primary procedures. Endografts might provide an alternative, avoiding dissection of a previously operated groin. Patients treated with a polytetrafluoroethylene-covered stents for superficial femoral artery occlusive disease between February 2009 and September 2011 were prospectively gathered. Demographics, clinical status, procedural aspects, and follow-up were retrieved. Seventy-four patients were included of which 5 (7%) were treated before with a femoropopliteal bypass. Indication for intervention was Rutherford category 3 in all patients and the median ankle-brachial index (ABI) was 0.68. Technical success was achieved in all cases. The postoperative course was uneventful in all and the ABI increased to 0.95. After a follow-up period of 18 months, 4 of 5 endografts remained patent. The use of endografts after failed femoropopliteal bypass surgery is feasible and safe and could be used to avoid or minimize a difficult and hazardous dissection of a previously operated area. 01 mei 2012
- Published
- 2012